RxDoctor Payments Data

Karen Dunn

Allergy & Immunology · Raleigh, NCNPI 1417955022

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $258,040 of the $258,040 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Cipla USA Inc.. Among allergy & immunology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$258,040in general payments, 2019–2025

Across 12 payments — averaging $21,503 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cipla USA Inc.$258K
$3,079,167in research payments, 2019–2025

Across 409 payments — averaging $7528.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Teva Pharmaceuticals USA, Inc.$646K
  • Cipla USA Inc.$586K
  • Chugai Pharmaceutical Co., Ltd.$466K
  • Romark Laboratories, LC$425K
  • AstraZeneca$382K
  • GSK$318K
  • plus $257K from 3 others

What the payments were for

  • Speaking & faculty fees$258,040100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Cipla USA Inc.12$258,040

How this compares

$258,040 in reported general payments places this provider in the 95th percentile of 140 allergy & immunology providers in North Carolina.

See all allergy & immunology providers in North Carolina

Other allergy & immunology in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →